Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 29,095 | 1,886 | 1,927 | 1,091 | 854 |
| Gross Profit | 29,095 | 1,886 | 1,927 | 1,091 | 854 |
| Operating Expenses | 27,389 | 28,409 | 19,518 | 15,989 | 13,247 |
| Operating Income | 1,705 | -26,523 | -17,591 | -14,898 | -12,394 |
| Other Income | 448 | 288 | 285 | 297 | 324 |
| Pre-tax Income | 2,153 | -26,235 | -17,306 | -14,601 | -12,069 |
| Net Income Continuous | 2,153 | -26,235 | -17,306 | -14,601 | -12,069 |
| Net Income | $2,153 | $-26,235 | $-17,306 | $-14,601 | $-12,069 |
| EPS Basic Total Ops | 0.90 | -12.91 | -9.01 | -7.81 | -6.31 |
| EPS Basic Continuous Ops | 1.00 | -12.77 | -9.10 | -7.66 | -6.34 |
| EPS Diluted Total Ops | 0.90 | -12.91 | -9.01 | -7.81 | -6.31 |
| EPS Diluted Continuous Ops | 0.94 | -12.77 | -9.10 | -7.66 | -6.34 |
| EBITDA(a) | $2,094 | $-26,370 | $-17,436 | $-14,766 | $-12,603 |